Antimicrobials · Nitroimidazoles
The facts most likely to be tested
Press 1–5 to rate · ↑↓ to navigate
Metronidazole is the first-line treatment for anaerobic infections below the diaphragm and protozoal infections including Giardia, Entamoeba histolytica, and Trichomonas vaginalis.
The mechanism of action involves the formation of toxic free radical metabolites that damage bacterial DNA and inhibit nucleic acid synthesis.
Patients must be warned to avoid alcohol consumption during therapy and for 48 hours after completion due to the disulfiram-like reaction.
Metronidazole is the drug of choice for Bacterial Vaginosis, characterized by clue cells on wet mount and a positive whiff test.
The drug is a critical component of quadruple therapy for the eradication of Helicobacter pylori in patients with penicillin allergies or macrolide resistance.
Common adverse effects include a metallic taste in the mouth, dark-colored urine, and, with prolonged high-dose use, peripheral neuropathy.
Metronidazole is the preferred treatment for non-severe Clostridioides difficile infection when oral vancomycin or fidaxomicin are unavailable or contraindicated.
Vignette unlocked
A 28-year-old female presents to the clinic complaining of a malodorous, thin, gray vaginal discharge. On physical examination, the vaginal pH is 5.2, and a whiff test with potassium hydroxide is positive. Microscopic evaluation of the discharge reveals clue cells with no evidence of hyphae or motile trichomonads. The patient denies any recent antibiotic use or systemic symptoms.
What is the most appropriate pharmacologic treatment for this patient's condition?
Metronidazole
The patient's presentation is classic for Bacterial Vaginosis, which is treated with Metronidazole as per the first bet.
Full handout
High yield triage
Classification
Nitroimidazole antibiotic; anaerobic and protozoal coverage.
Indications
Bacterial vaginosis, trichomoniasis, C. difficile (non-severe), and anaerobic intra-abdominal infections.
Mechanism of Action
Reductive activation by anaerobic organisms leads to DNA strand breakage.
Side Effects
Metallic taste, nausea, disulfiram-like reaction, peripheral neuropathy.
Contraindications / Monitoring
First trimester pregnancy; alcohol consumption; monitor for seizures or neuropathy.
Full handout
Mechanism of Action
Metronidazole is a prodrug that requires reductive activation by anaerobic or microaerophilic organisms. The reduced intermediate binds to bacterial DNA, causing helical structure loss and strand breakage. This process effectively inhibits nucleic acid synthesis and results in cell death. It is selectively toxic to organisms capable of reducing the nitro group.
Unique Properties
It provides excellent coverage against anaerobes (e.g., Bacteroides fragilis) and specific protozoa. Unlike many antibiotics, it is highly effective for protozoal infections like Giardia and Entamoeba histolytica. It is often used in combination with other agents to provide broad-spectrum coverage for polymicrobial infections.
Indications
First-line treatment for bacterial vaginosis and trichomoniasis. It is a secondary agent for C. difficile infection (non-severe), used only when oral vancomycin or fidaxomicin are unavailable, and is used for pelvic inflammatory disease (in combination). It is also indicated for amebic liver abscess and giardiasis.
Pharmacokinetics
Metronidazole is well-absorbed orally and achieves high concentrations in cerebrospinal fluid and abscess cavities. It undergoes extensive hepatic metabolism; dosage adjustments are generally not required for renal impairment but are necessary in severe hepatic disease. It is a potent inhibitor of CYP2C9, leading to significant interactions with warfarin.
Side Effects & Adverse Events
Common effects include a metallic taste and GI distress. Disulfiram-like reaction occurs with alcohol, causing severe flushing, tachycardia, and vomiting. Prolonged use may lead to peripheral neuropathy or seizures. Rare but serious pancreatitis and encephalopathy have been reported.
Contraindications
First trimester pregnancy is a classic board contraindication due to potential teratogenicity. Hypersensitivity to nitroimidazoles is an absolute barrier. Alcohol consumption must be strictly avoided during and for 48 hours after therapy to prevent a disulfiram-like reaction.
Monitoring
Monitor for signs of neuropathy (numbness/tingling) during long-term therapy. Assess for CNS toxicity, including ataxia or confusion. No routine laboratory monitoring is required for short-course therapy, but monitor INR closely if the patient is on warfarin.
Clinical Pearls
Always look for the clue cells buzzword in bacterial vaginosis or strawberry cervix in trichomoniasis as the trigger for metronidazole. Remember it is the classic answer for anaerobic coverage below the diaphragm. If a patient presents with a metallic taste and nausea while on antibiotics, suspect metronidazole.